Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis™, a ...

A recent US study raises concerns about the increasing use of CT scans in India, potentially leading to a rise in ...

A new liquid biopsy approach developed by Johns Hopkins Kimmel Cancer Center investigators could revolutionize brain cancer ...

Updated findings from a phase 2 study investigating the IL-2–binding monoclonal antibody AU-007 show a manageable safety ...

A new liquid biopsy approach developed by Johns Hopkins Kimmel Cancer Center investigators could revolutionize brain cancer ...

An ultrasensitive circulating tumor DNA (ctDNA)-based liquid biopsy assay detected signs of recurrence prior to imaging and ...

Additionally, the evolving national disease registries lack information about sarcoidosis, and limited awareness among ...

Aulostm Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic, today presented positive results from its ...

Learn about dismissed symptoms that might indicate serious medical conditions requiring immediate surgical intervention and ...

Special to IFN Did you know tobacco use is the leading cause of most preventable deaths in the United States? Although the ...

Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access.

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...